Dimensional Fund Advisors
ADIL

Dimensional Fund Advisors’s Adial Pharmaceuticals ADIL Stock Holding History

Dimensional Fund Advisors’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$63K – 3461
2022
Q1 		$63K Hold
50
– – ﹤0.01% 3442
2021
Q4 		$85K Hold
50
– – ﹤0.01% 3452
2021
Q3 		$135K Hold
50
– – ﹤0.01% 3396
2021
Q2 		$80K Hold
50
– – ﹤0.01% 3420
2021
Q1 		$76K Buy
50
+20
+67% +$30.2K ﹤0.01% 3372
2020
Q4 		$32K Buy
+30
New +$35.4K ﹤0.01% 3334

Other funds holding ADIL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Dimensional Fund Advisors's ADIL Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Adial Pharmaceuticals (ADIL) in Q2 2022, closing a stake of 50 shares — an estimated $63K sold.

Dimensional Fund Advisors first reported a position in ADIL in Q4 2020 and held it in 6 quarters. The position peaked at $135K in Q3 2021. 25 funds tracked by Wall St. Rank hold ADIL as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Adial Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 50 Adial Pharmaceuticals shares in Q2 2022, an estimated $63K.
  • Dimensional Fund Advisors first reported a position in Adial Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Dimensional Fund Advisors's Adial Pharmaceuticals position peaked at $135K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.